Germany's Symrise to sell terpenes business, take $169 million impairment charge
Jan 12 (Reuters) - German fragrances maker Symrise AG SY1G.DE said on Monday it is in advanced talks to sell its terpenes business and that it would take a non-cash impairment of about 145 million euros ($169.22 million) in the fourth quarter. ($1 = 0.8569 euros) (Reporting by Carlos Méndez in Mexico City; Editing by Sahal Muhammed) ((Carlos.Mendez@thomsonreuters.com;))
Recent news on Symrise AG
See all newsBrief: Symrise AG - Invests In Additional Global Production Capacity For Globalide In India
Givaudan jumps on fragrance outperformance; peers follow
Brief: Brenntag Enters Distribution Agreement With Symrise In Brazil
Europe Research Roundup: Akzo Nobel, MTU Aero Engines, Symrise
Europe Research Roundup: Akzo Nobel, MTU Aero Engines, Symrise